Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.

MLA

Vargas-Parra, Gardenia M., et al. “Elucidating the Molecular Basis of MSH2-Deficient Tumors by Combined Germline and Somatic Analysis.” International Journal of Cancer, vol. 141, no. 7, Oct. 2017, pp. 1365–80. EBSCOhost, https://doi.org/10.1002/ijc.30820.

APA

Vargas-Parra, G. M., González-Acosta, M., Thompson, B. A., Gómez, C., Fernández, A., Dámaso, E., Pons, T., Morak, M., Del Valle, J., Iglesias, S., Velasco, À., Solanes, A., Sanjuan, X., Padilla, N., de la Cruz, X., Valencia, A., Holinski-Feder, E., Brunet, J., Feliubadaló, L., … Capellá, G. (2017). Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis. International Journal of Cancer, 141(7), 1365–1380. https://doi.org/10.1002/ijc.30820

Chicago

Vargas-Parra, Gardenia M, Maribel González-Acosta, Bryony A Thompson, Carolina Gómez, Anna Fernández, Estela Dámaso, Tirso Pons, et al. 2017. “Elucidating the Molecular Basis of MSH2-Deficient Tumors by Combined Germline and Somatic Analysis.” International Journal of Cancer 141 (7): 1365–80. doi:10.1002/ijc.30820.